New Analyst Searches Corporate Calendar Upcoming Dividends Upcoming Floats Stock Screener Featured Stock ASX300 News Digest Our Research Methodology
Company News Summary
ResMed Appoints CEO
27 Feb 2013 | 14:12:00 | Associate analysts | Increase | Decrease | 
Original announcement: ResMed Appoints CEO & COO
ResMed reported that on February 20, 2013, the board approved the appointment of Michael Farrell as the company's CEO, to be effective March 1, 2013. Mr. Farrell has served as the company's president - Americas since May 2011. In addition to his appointment as CEO, Mr. Farrell was appointed to serve as a director on the board effective as of March 1, 2013. At this time, the company does not expect Mr. Farrell to serve on any of the board's committees. On February 20, 2013, and in connection with the appointment of Mr. Farrell as CEO, the board determined that Peter Farrell, the current chairman of the board, president, and CEO of the company, will serve solely as executive chairman of the board effective as of March 1, 2013.
See more ASX300 News Announcements